Showing results (361-370 of 445) with videos related to

Sort By:
Pageof 45
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancerShuji Ogino, Jeffrey A Meyerhardt, Mami Cantor, et al.
JCO Precision Oncology|March 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 StudiesYelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
Neurology|May 18, 2012
Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS studyH Jokinen, J Lipsanen, R Schmidt, et al.
Neuroradiology|January 6, 2010
Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosisI J van den Elskamp, B Boden, V Dattola, et al.
Journal of Palliative Medicine|March 17, 2022
Developing and Field Testing BOLSTER: A Nurse-Led Care Management Intervention to Support Patients and Caregivers following Hospitalization for Gynecologic Cancer-Associated Peritoneal CarcinomatosisRachel A Pozzar, Andrea C Enzinger, Hanneke Poort, et al.
Scientific Reports|December 1, 2019
Parametrization of energy sharing distributions in direct double photoionization of HeJ Andersson, S Zagorodskikh, A Hult Roos, et al.
Neurology|January 8, 2010
MRI criteria for MS in patients with clinically isolated syndromesX Montalban, M Tintoré, J Swanton, et al.
Neurology|May 10, 2006
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answersR M Burwick, P P Ramsay, J L Haines, et al.
Seminars in Thoracic and Cardiovascular Surgery|December 22, 2015
The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and RadiationRona Spector, Yifan Zheng, Beow Y Yeap, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2009
Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancerP C Enzinger, D P Ryan, J W Clark, et al.
Pageof 45